- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A P3 Pharmacy interview featuring Teva content was ruled promotional. The article lacked PI, AE reporting statement, certification and Ajovy’s black triangle,…
ABN slide deck and summary for a natalizumab biosimilar were ruled to go beyond permitted advance budgetary notification and amount to pre-authorisation…
A UK senior employee ‘liked’ a global corporate LinkedIn post linking to product milestone news. The Panel said this proactively disseminated promotional…
Anonymous HCP alleged Roche’s Ocrevus promotional webpage implied only 1 hour monitoring and omitted “dedicated line” administration. Panel found the timeline clearly…
A third-party newsletter ran a “Sponsored” block linking to AZ’s Forxiga promotional microsite, but the email didn’t name AstraZeneca, didn’t make the…
PMCPA case AUTH/3870/1/24 against AstraZeneca concerned allegations about clinical trial material. The matter was found outwith the scope of the ABPI Code:…
Complaint alleged Proveca’s Sialanar pages were promoted via Google/SEO and inaccessible to the public. Panel found search results reflected Google indexing, HCP…
A health professional complained that a patient accessed the Eylea SmPC via Bayer’s patient website. The Panel found the site appropriately separated…
PMCPA ruled AstraZeneca breached Clause 5.5 after sponsorship of a severe asthma article was only declared in an acknowledgements section near the…
Complaint alleged a third‑party promotional email for Xarelto omitted contraindications/special warnings (renal impairment) and breached a prior undertaking. PMCPA Panel ruled no…
Complaint alleged Roche sponsorship wasn’t declared prominently from the outset on a partnership website and breached a prior undertaking. PMCPA Panel found…
A BBC radio programme about a Roche-sponsored eye health campaign featured partner interviews without declaring Roche’s sponsorship during the audio. PMCPA ruled…
A UK health professional complained that a BMJ-hosted DuoResp Spiromax ad implied broader licensed use than permitted and relied on footnotes. The…
Allergan challenged Xeomin promotional claims in a BMJ ad, leavepiece and conference stand panels. The Panel ruled some claims misleading about complexing…
A competitor challenged Guerbet’s exhibition claim that Dotarem had the “highest Stability”. Although the claim was considered true, the context could imply…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.